New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)
Public ClinicalTrials.gov record NCT00035854. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Linezolid IV/PO for the Treatment of Vancomycin-Resistant Enterococcus Infections in Children
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will treat pediatric patients who have infections that are due to a specific bacteria (Vancomycin-Resistant Enterococcus)
Study identification
- NCT ID
- NCT00035854
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 13 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Up to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2002 (Type not available)
- Primary completion
- Not listed
- Completion
- May 2004 (Actual)
- Last update posted
- Aug 14, 2009
2002 – 2004
United States locations
- U.S. sites
- 21
- U.S. states
- 15
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Center | Long Beach | California | 90806 | — |
| Research Center | Los Angeles | California | 90027 | — |
| Research Center | Los Angeles | California | 90095 | — |
| Research Center | Hartford | Connecticut | 06106 | — |
| Research Center | Washington D.C. | District of Columbia | 20010 | — |
| Research Center | Gainesville | Florida | 32610 | — |
| Research Center | Atlanta | Georgia | 30342 | — |
| Research Center | Chicago | Illinois | 60614 | — |
| Research Center | Park Ridge | Illinois | 60068 | — |
| Research Center | Louisville | Kentucky | 40202 | — |
| Research Center | Baltimore | Maryland | 21287 | — |
| Research Center | Boston | Massachusetts | 02111 | — |
| Research Center | Detroit | Michigan | 48201 | — |
| Research Center | Camden | New Jersey | 08103 | — |
| Research Center | New York | New York | 10021 | — |
| Research Center | New York | New York | 10029 | — |
| Research Center | New York | New York | 10032 | — |
| Research Center | Cleveland | Ohio | 44195 | — |
| Research Center | Danville | Pennsylvania | 17822 | — |
| Research Center | Philadelphia | Pennsylvania | 19104 | — |
| Research Center | Austin | Texas | 78701 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00035854, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 14, 2009 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00035854 live on ClinicalTrials.gov.